Short description
Neoleukin Therapeutics is a pharmaceutical company that develops medicines to treat serious immunological disorders.
Description
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. They are creating next generation immunotherapies using breakthrough de novo protein design technology. They use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
Last funding
Cannot Access
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Seattle, Washington, United States, North America
Founded on
December 1, 2003
Exited on
July 18, 2023
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh
Sign in for full access
Founders
Jonathan Drachman